US11179402 — Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Composition of Matter · Assigned to Clarus Therapeutics Inc · Expires 2026-04-14 · 0y expired
What this patent protects
This patent protects a drug delivery system for oral administration of hydrophobic drugs, including formulations of testosterone and its esters, such as testosterone palmitate.
USPTO Abstract
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Drugs covered by this patent
- Aveed (TESTOSTERONE UNDECANOATE) · Marius
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.